OTCMLOVFF
Market cap51mUSD
Jan 08, Last price
0.57USD
1D
3.18%
1Q
30.89%
IPO
-2.16%
Name
Cannara Biotech Inc
Chart & Performance
P/E
11.43
P/S
0.90
EPS
0.07
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
108.05%
Revenues
82m
+42.77%
Net income
6m
-7.30%
CFO
11m
+80.72%
Earnings
Jan 27, 2025
Profile
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑08 | 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | |
| Income | |||||||
Revenues | 81,748 42.77% | 57,260 59.76% | 35,841 110.58% | ||||
Cost of revenue | 72,729 | 44,580 | 29,793 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 9,018 | 12,680 | 6,048 | ||||
NOPBT Margin | 11.03% | 22.14% | 16.87% | ||||
Operating Taxes | (1,955) | 1,918 | |||||
Tax Rate | 31.71% | ||||||
NOPAT | 10,973 | 12,680 | 4,130 | ||||
Net income | 6,438 -7.30% | 6,945 201.26% | 2,305 -250.86% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | (277) | (374) | 25 | ||||
BB yield | |||||||
| Debt | |||||||
Debt current | 9,505 | 6,045 | 2,188 | ||||
Long-term debt | 39,470 | 39,915 | 46,440 | ||||
Deferred revenue | 945 | 857 | 817 | ||||
Other long-term liabilities | (46,187) | ||||||
Net debt | 42,354 | 41,689 | 36,514 | ||||
| Cash flow | |||||||
Cash from operating activities | 10,683 | 5,911 | (6,079) | ||||
CAPEX | (7,469) | (9,879) | (15,467) | ||||
Cash from investing activities | (5,188) | (9,478) | (15,345) | ||||
Cash from financing activities | (3,145) | (3,719) | 25,464 | ||||
FCF | (2,164) | (6,562) | (22,314) | ||||
| Balance | |||||||
Cash | 6,620 | 4,271 | 12,115 | ||||
Long term investments | |||||||
Excess cash | 2,533 | 1,408 | 10,323 | ||||
Stockholders' equity | 75,625 | 69,394 | 57,012 | ||||
Invested Capital | 134,690 | 124,977 | 59,115 | ||||
ROIC | 8.45% | 13.78% | 7.04% | ||||
ROCE | 6.57% | 10.03% | 5.23% | ||||
| EV | |||||||
Common stock shares outstanding | 89,300 | 87,840 | |||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | 15,371 | 17,622 | 9,969 | ||||
EV/EBITDA | |||||||
Interest | 4,327 | 4,292 | 1,918 | ||||
Interest/NOPBT | 47.99% | 33.85% | 31.71% | ||||